Vigabatrin in partial seizures in children

Journal of Child Neurology

Volumn 12, Issue 3, 1997, Pages 172-177

  Nabbout, Rima C ^a   Chiron, Catherine ^a   Mumford, John ^b   Dumas, Caroline ^c   Dulac, Olivier ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b Marion Merrell Ltd UK   (United Kingdom)

^c Marion Merrell Dow SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; VIGABATRIN;

ADULT; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; BRAIN TUMOR; CHILD; DRUG EFFICACY; EPILEPTIC FOCUS; FOCAL EPILEPSY; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RECURRENCE RISK; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

EID: 0030939610     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389701200304     Document Type: Article

References (31)

1. Browne TR, Mattson RH, Penry JK, et al: Vigabatrin for refractory complex partial seizures: Multicenter single blind study with long term follow-up. Neurology 1987;37:184-189.
2. Cocito L, Maffini M, Perfumo P, et al: Vigabatrin in complex partial seizures: A long term study. Epilepsy Res 1989;3:160-166.
3. Gram L, Klosterkov P, Dam M: Gamma vinyl GABA: A double blind placebo controlled trial in partial epilepsy. Ann Neurol 1985;17: 262-266.
4. Grant SM, Heel RC: Vigabatrin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 1991;41:889-926.
5. Loiseau P, Hardenberg JP, Pestre M, et al: Double blind, placebo controlled study of vigabatrin (gamma vinyl GABA) in drug resistant epilepsy. Epilepsia 1986;27:115-120.
6. Michellucci R, Tassinari CA: Response to vigabatrin in relation to seizure type. Br J Clin Pharmacol 1989;27(Suppl):S119-S124.
7. Reynolds EH: Gamma vinyl GABA (vigabatrin): Clinical experience in adults and adolescent patients with intractable epilepsy. Epilepsia 1992;33(Suppl 5):S30-S35.
8. Sander JW, Trevisol-Bittencourt PC, Hart YM, Shoruon SD: Evaluation of vigabatrin as add-on therapy in the management of severe epilepsy. J Neurol Neurosurg Psychiatry 1989;52:467-471.
9. Silvenius J, Ylinean A, Murros K, et al: Vigabatrin in drug resistant partial epilepsy, a 5 year follow-up study. Neurology 1991;41: 562-565.
10. The Italian Study Group on Vigabatrin. Single-blind, placebo-controlled trial of vigabatrin in the treatment of epilepsy. Ital J Neurol Sci 1992;13:741-747.
11. Chiron C, Dulac O, Beaumont D, et al: Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991;6(Suppl): 2S52-2S59.
12. Dulac O, Chiron C, Luna D, et al: Vigabatrin in childhood epilepsy. J Child Neurol 1991;6(Suppl):2S30-2S37.
13. Gibbs JM, Appleton RE, Rosenbloom LR: Vigabatrin in intractable childhood epilepsy: A retrospective study. Pediatr Neurol 1992;8: 338-340.
14. Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J: Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 1989;27:1095-1125.
15. Luna D, Dulac O, Pajot N, Beaumont D: Vigabatrin in the treatment of childhood epilepsies: A single-blind placebo-controlled study. Epilepsia 1989;30:430-437.
16. Appleton RE, Monteil-Viecca F: Vigabatrin in infantile spasms. Why add-on? Lancet 1992;341:962.
17. Buti D, Lini M, Bardini R, et al: Early treatment of infantile spasms with vigabatrin monotherapy: Results in 4 patients. Epilepsia 1991;32(Suppl 1):89.
18. Vles JS, Van der Heyden AM, Ghijs A, Troos J: Vigabatrin in the treatment of infantile spasms. J Neuropediatrics 1993;24:230-231.
19. Lortie A, Chiron C, Mumford JP, Dulac O: The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 1993;43(Suppl 5):S24-S27.
20. Knott C, Panayiotopoulos CP: Vigabatrin in the treatment of partial seizures. Seizure 1992;1:167-172.
21. Michellucci R, Cavaciocchi P, Riguzzi P, et al: Single blind, placebo controlled dose modification study of vigabatrin in refractory epileptic patients. J Epilepsy 1992;5:248-252.
22. Mumford JP, Dam M: Metaanalysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 1989;27:101S-107S.
23. Remy C, Beaumont D: Efficacy and safety of vigabatrin in the long term treatment of refractory epilepsy. Br J Clin Pharmacol 1989; 27(Suppl 1):S125-S129.
24. Reynolds EH, Ring HA, Fair IN, et al: Open, double blind and long term study of vigabatrin in chronic epilepsy. Epilepsia 1991;32: 530-538.
25. Sutula T, Xiao-Xian H, Cavazos J, Scott G: Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science 1988;239:1147-1150.
26. Represa A, Robain O, Tremblay E, Ben Ari Y: Hippocampal plasticity in childhood epilepsy. Neurosci Lett 1989;99:351-355.
27. Marciani MG, Gigli M, Orlandi L: Long follow-up of tuberous sclerosis treated with vigabatrin. Lancet 1992;340:1554.
28. Browne TR, Mattson RH, Penry JK, et al: Multicenter long-term safety and efficacy of vigabatrin for refractory complex partial seizures: An update. Neurology 1991;41:363-364.
29. Tartara A, Manni R, Galimberti CA, et al: Vigabatrin in the treatment of epilepsy: A long term follow-up study. J Neurol Neurosurg Psychiatry 1989;52:467-471.
30. Tartara A, Manni R, Galimberti CA, et al: Six years follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Acta Neurol Scand 1992;86:247-251.
31. Moshe S: Seizures in the developing brain. Neurology 1993;43(Suppl 5):S3-S7.